Inventor · disambiguated record
Anthony Possemato
Also filed as: POSSEMATO ANTHONY · POSSEMATO ANTHONY PAUL
17 granted patents·17 pending applications·59 citations·filing 2007–2021
93Inventor score
Top patents by PatentIndex Score
34 records- 0195US7700339B2Gene defects and mutant ALK kinase in human solid tumorsCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Apr 20, 2010·22 cites·15 claims
- 0292US8232060B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2009·Granted Jul 31, 2012·6 cites·60 claims
- 0390US8481279B2Methods of treating lung cancer using inhibitors anaplastic lymphoma kinaseRIKOVA KLARISA·Filed 2012·Granted Jul 9, 2013·6 cites·24 claims
- 0490US8288102B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2010·Granted Oct 16, 2012·5 cites·40 claims
- 0589US8383799B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2008·Granted Feb 26, 2013·5 cites·5 claims
- 0689US8377642B2Gene defects and mutant ALK kinase in human solid tumorsCELL SIGNALING TECHNOLOGY INC·Filed 2010·Granted Feb 19, 2013·5 cites·36 claims
- 0783US8168383B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2009·Granted May 1, 2012·5 cites·7 claims
- 0882US9523130B2Methods of treating non-small cell lung carcinoma (NSCLC)CELL SIGNALING TECHNOLOGY INC·Filed 2016·Granted Dec 20, 2016·1 cites·29 claims
- 0980US9988688B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2015·Granted Jun 5, 2018·1 cites·15 claims
- 1080US8486645B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2012·Granted Jul 16, 2013·2 cites·12 claims
- 1177US11505833B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Nov 22, 2022·0 cites·10 claims
- 1274US11761005B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Sep 19, 2023·0 cites·10 claims
- 1373US10870892B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Dec 22, 2020·0 cites·12 claims
- 1473US2015184158A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2014·Application pending·0 cites
- 1570US10955416B2Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Mar 23, 2021·0 cites·9 claims
- 1668US2021349095A1Ros kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1767US2018156802A1Methods of treating lung cancer by administration of an alk inhibitorCELL SIGNALING TECHNOLOGY INC·Filed 2017·Application pending·0 cites
- 1864US11099188B2ROS kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Aug 24, 2021·0 cites·4 claims
- 1962US2014134640A1Gene Defects And Mutant ALK Kinase In Human Solid TumorsCELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 2062US2013071841A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2012·Application pending·0 cites
- 2161US2013209452A1Gene defects and mutant alk kinase in human solid tumorsRIKOVA KLARISA·Filed 2012·Application pending·0 cites
- 2260US7977462B2Tyrosine phosphorylation sitesCELL SIGNALING TECHNOLOGY INC·Filed 2008·Granted Jul 12, 2011·1 cites·2 claims
- 2354US10889818B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaGUO AILAN·Filed 2012·Granted Jan 12, 2021·0 cites·5 claims
- 2452US2010143918A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2009·Application pending·0 cites
- 2550US2010304406A1Protein Phosphorylation by Serine/Threonine Kinases in Insulin Signaling PathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2009·Application pending·0 cites
- 2647US2012208824A1ROS Kinase in Lung CancerRIMKUNAS VICTORIA MCGUINNESS·Filed 2011·Application pending·0 cites
- 2744US2009068684A1Serine and threoninephosphorylation sitesCELL SIGNALING TECHNOLOGY INC·Filed 2008·Application pending·0 cites
- 2843US2010093000A1Tyrosine phosphorylation sitesCELL SIGNALING TECHNOLOGY INC·Filed 2008·Application pending·0 cites
- 2943US2010120055A1Tyrosine phosphorylation sitesCELL SIGNALING TECHNOLOGY INC·Filed 2007·Application pending·0 cites
- 3039US2011104820A1Tyrosine, Serine, And Threonine Phosphorylation SitesCELL SIGNALING TECHNOLOGY INC·Filed 2010·Application pending·0 cites
- 3138US2011059463A1Serine and Threonine Phosphorylation SitesCELL SIGNALING TECHNOLOGY INC·Filed 2010·Application pending·0 cites
- 3236US2011143368A1Tyrosine phosphorylation sitesCELL SIGNALING TECHNOLOGY INC·Filed 2010·Application pending·0 cites
- 3332US2011045603A1Serine, Threonine, and Tyrosine Phosphorylation SitesCELL SIGNALING TECHNOLOGY INC·Filed 2010·Application pending·0 cites
- 3428US2010173428A1Protein Phosphorylation By Basophillic Serine/Threonine KinasesGUO AILAN·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →